Macrocyclic lactones are a family of chemical compounds, produced naturally by soil bacteria, that kill parasitic worms and arthropod pests by permanently jamming open specific ion channels in their nervous systems. The two main subfamilies, avermectins and milbemycins, are among the most widely used antiparasitic drugs on the planet, deployed in veterinary medicine, human health, and agriculture. Ivermectin, the most famous member, has been given in over 800 million doses for a single tropical disease alone, and the broader drug class remains the backbone of parasite control in livestock worldwide.
Where Macrocyclic Lactones Come From
The avermectins were discovered in the late 1970s as fermentation products of a soil-dwelling bacterium called Streptomyces avermitilis. These secondary metabolites turned out to be extraordinarily potent against parasites at very low doses. Avermectin has four structural components, each with a major and minor subcomponent, and of these, avermectin B1a proved the most effective for parasite control.1PubMed Central. Potential of Streptomyces avermitilis: A Review on Avermectin Production and Its Biocidal Effect Ivermectin is a chemically modified derivative of that compound, and most members of the avermectin subfamily are either direct fermentation products or semi-synthetic tweaks of them. Doramectin, another avermectin used mainly in cattle, is produced by feeding the bacterium a specific precursor during fermentation to steer the chemical output.
The milbemycins, the other subfamily, are structurally similar but differ in a few important ways. They lack the sugar groups that avermectins carry at one position on the molecule, and they have a simpler substitution pattern at another.2International Journal for Parasitology: Drugs and Drug Resistance. Moxidectin and the avermectins: Consanguinity but not identity Moxidectin, the best-known milbemycin in clinical use, shares its basic ring structure with ivermectin but behaves differently in the body. These chemical differences matter for how long each drug persists in tissues, how it distributes through the body, and how individual parasites respond to it.
How They Kill Parasites
Macrocyclic lactones target a type of ion channel found in the nerve and muscle cells of invertebrates: glutamate-gated chloride channels. These channels are unique to invertebrates and have no equivalent in mammals, which is why the drugs can be used safely at therapeutic doses in people and animals.3PubMed Central. Glutamate-gated chloride channels
When ivermectin or moxidectin binds to one of these channels, it forces the channel open slowly but essentially permanently. The natural signaling molecule, glutamate, opens the same channels in quick, brief bursts that let the cell reset between signals. The drug-induced opening is fundamentally different: the channel stays locked open, flooding the cell with chloride ions and shutting down the electrical activity the cell needs to function.4PubMed. Glutamate-gated chloride channels and the mode of action of the avermectin/milbemycin anthelmintics In parasitic worms, this paralysis hits the pharyngeal muscles (the worm’s feeding pump) and the body-wall muscles. The worm can no longer feed or move, and the host’s immune system clears it.
Both ivermectin and moxidectin bind to the same site on the channel, though they arrive there with slightly different affinities. Interestingly, the presence of glutamate itself enhances how tightly the drugs bind, amplifying their effect.5PubMed. A glutamate-gated chloride channel subunit from Haemonchus contortus: expression in a mammalian cell line, ligand binding, and modulation of anthelmintic binding by glutamate This cooperative relationship between the natural transmitter and the drug helps explain why such tiny doses are enough to overwhelm the parasite’s nervous system.
Why They Are Safe for Mammals (Usually)
Mammals do not have glutamate-gated chloride channels. They do, however, have a related set of chloride channels gated by a different signaling molecule, GABA, and macrocyclic lactones can interact with those at high enough concentrations. The reason this does not normally cause problems is that GABA receptors in mammals are confined to the brain and spinal cord, and the blood-brain barrier keeps the drugs out. A protein pump called P-glycoprotein, encoded by the MDR1 gene, sits at the blood-brain barrier and actively ejects macrocyclic lactones back into the bloodstream before they can reach brain tissue.6PubMed Central. Treatment of MDR1 mutant dogs with macrocyclic lactones
This system works well in most animals, but it fails in a well-known group of dog breeds. Collies and several related herding breeds carry a deletion mutation in the MDR1 gene that prevents them from making functional P-glycoprotein.7PubMed. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene Dogs that are homozygous for this mutation (carrying two copies of the defective gene) lack the protective pump entirely. When given standard doses of ivermectin, the drug crosses freely into the brain, producing severe neurological toxicity that can be fatal.8PubMed. Brain penetration of ivermectin and selamectin in mdr1a,b P-glycoprotein- and bcrp- deficient knockout mice Dogs with one normal copy and one mutant copy do not show increased sensitivity, so the trait is recessive.9PubMed. MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin Genetic testing is now routine in breeds at risk, and veterinarians adjust drug choice and dosing accordingly. Some macrocyclic lactones given at heartworm-prevention doses are low enough to be safe even in MDR1-mutant dogs, but the margin depends on the specific compound and route.
Veterinary Uses
Macrocyclic lactones are the single most important class of antiparasitic drugs in livestock production. They are active against an unusually broad range of parasites: internal worms (nematodes) as well as external pests like lice, mites, and ticks.10PubMed Central. Macrocyclic lactones and ectoparasites control in livestock: Efficacy, drug resistance and therapeutic challenges This dual action made them revolutionary when they were first introduced in the 1980s, and they remain the go-to treatment in cattle, sheep, goats, horses, and swine operations worldwide.
In companion animals, the most familiar use is heartworm prevention. Products containing ivermectin, milbemycin oxime, selamectin, or moxidectin are given to dogs and cats monthly as oral tablets, topical spot-on treatments, or long-acting injectable formulations.11PubMed. Macrocyclic lactones in the treatment and control of parasitism in small companion animals These drugs kill heartworm larvae during their early development stages, preventing the parasite from reaching the heart and pulmonary arteries where it causes life-threatening disease.12PubMed Central. Concern for Dirofilaria immitis and Macrocyclic Lactone Loss of Efficacy: Current Situation in the USA and Europe, and Future Scenarios
Long-acting delivery systems have extended how these drugs can be used in the field. A non-degradable sustained-release device loaded with moxidectin, implanted under the skin in sheep, extended protection against a common parasitic worm from about 42 days with a standard injection to 183 days with the implant, potentially covering an entire grazing season with a single treatment.13PubMed. Sustained-release delivery systems and their application for endoparasite control in animals Similar sustained-release injectable formulations of moxidectin are used in dogs for heartworm prevention, offering six months or more of coverage per dose.
Human Medicine
Ivermectin’s most celebrated human application is the control of onchocerciasis, commonly called river blindness. Caused by a parasitic worm transmitted by blackflies, onchocerciasis causes severe skin disease and irreversible blindness. In 1987, Merck donated ivermectin (under the brand name Mectizan) for mass distribution, and over the following decades more than 800 million doses were given to over 80 million people. The effort significantly reduced the disease in more than 25 countries and interrupted transmission entirely in at least 10.14PubMed Central. Importance of ivermectin to human onchocerciasis: past, present, and the future The 2015 Nobel Prize in Physiology or Medicine went in part to the scientists behind avermectin’s discovery, recognizing its impact on global health.
Macrocyclic lactones also play a role in the global effort to eliminate lymphatic filariasis, another mosquito-borne worm disease that causes the painful swelling known as elephantiasis. Pharmaceutical companies including MSD (Merck’s international name) have donated ivermectin as part of a broad public-private partnership coordinating mass drug administration programs across endemic countries.15PubMed Central. The role of medicine donations in the global programme for the elimination of lymphatic filariasis
Beyond tropical parasitic diseases, ivermectin has established medical uses in dermatology. Oral ivermectin is a standard treatment for scabies, a skin infestation caused by burrowing mites. Two doses of oral ivermectin given two weeks apart provide cure rates around 95%.16PubMed. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies Topical ivermectin is also used for scabies, with one study reporting an 82% cure rate after two rounds of treatment, outperforming the comparison cream.17PubMed. Topical ivermectin versus crotamiton cream 10% for the treatment of scabies In rosacea, a chronic facial skin condition, topical ivermectin cream has shown effectiveness against both the inflammatory component and the Demodex mites that are thought to contribute to the disease. Trials found it more effective than metronidazole, the previous standard topical treatment, at reducing lesion counts and improving patients’ quality of life.18PubMed Central. New developments in the treatment of rosacea – role of once-daily ivermectin cream
Agricultural Pest Control
Abamectin, the unmodified natural avermectin B1, is registered as a crop pesticide for controlling mites and insect pests on a range of agricultural and horticultural plants. It is used as a foliar spray on ornamental plants, citrus, cotton, pears, and various vegetable crops, applied at very low rates of roughly 5 to 27 grams per hectare.19PubMed. Abamectin as a pesticide for agricultural use Those extremely low application rates are characteristic of the whole class: because macrocyclic lactones work at nanomolar concentrations on their target channels, a small amount of active ingredient goes a long way compared to conventional broad-spectrum pesticides. Abamectin also breaks down rapidly in sunlight on leaf surfaces, which limits its persistence in the environment after application, though this also means it works primarily through contact and ingestion rather than as a long-lasting residue.
The Environmental Trade-Off
One of the persistent concerns about macrocyclic lactones involves what happens after a treated animal excretes the drug. These compounds are highly fat-soluble and tend to concentrate in lipid-rich tissues, which leads to slow elimination from the body and prolonged excretion in dung. Ivermectin residues in cattle and sheep dung have been shown to harm the insects that depend on dung for their life cycle, particularly dung beetles, which play a critical role in breaking down manure and recycling nutrients in pasture ecosystems.
In sheep, dung produced during the first day after ivermectin drenching caused mortality in newly emerged dung beetles and reduced the reproductive output of surviving adults. Beetle larvae exposed to dung from the first two days post-treatment suffered 100% mortality, though by day five there was no longer evidence of acute toxicity.20PubMed. Effects of ivermectin residues in sheep dung on the development and survival of the bushfly, Musca vetustissima Walker and a scarabaeine dung beetle, Euoniticellus fulvus Goeze In cattle, the situation tends to last longer because of differences in drug formulation and slower drug elimination.
When ivermectin-laden dung enters waterways, aquatic invertebrates are also at risk. Laboratory studies have shown that at concentrations realistically found in dung, ivermectin can kill water fleas outright and severely impair the growth and emergence of midge larvae. At the highest test concentrations, toxic effects persisted for weeks after a single exposure event.21PubMed. Effects of ivermectin-spiked cattle dung on a water-sediment system with the aquatic invertebrates Daphnia magna and Chironomus riparius
Not all macrocyclic lactones pose equal environmental risk. Comparisons between ivermectin and moxidectin in adult dung beetles found that the threshold concentration needed to harm beetles was about ten times higher for moxidectin than for ivermectin. Despite moxidectin taking longer to clear from dung, its lower toxicity to non-target insects means it may be substantially less harmful to dung beetle populations in real-world conditions.22Scientific Reports. First assessment of the comparative toxicity of ivermectin and moxidectin in adult dung beetles: Sub-lethal symptoms and pre-lethal consequences This is one reason some researchers and regulators favor moxidectin-based products where dung beetle conservation is a concern.
Drug Resistance and Its Consequences
After decades of heavy use, resistance to macrocyclic lactones has become a serious and growing problem. In livestock, several species of gastrointestinal nematodes have developed populations that survive standard drug doses, particularly the barber pole worm Haemonchus contortus in sheep and goats. Research has identified genetic changes in these resistant worms, including changes in the expression and sequence of specific genes. One study found that a dopamine-gated ion channel gene was significantly down-regulated in resistant strains of H. contortus, and a single-nucleotide change in the gene’s regulatory region appeared to be linked to drug selection pressure.23PubMed. A dopamine-gated ion channel (HcGGR3*) from Haemonchus contortus is expressed in the cervical papillae and is associated with macrocyclic lactone resistance The reality is that resistance is likely driven by multiple genetic mechanisms working together, not a single mutation, which makes it harder to track and harder to reverse.
The resistance picture is especially alarming for heartworm in dogs. Macrocyclic lactones are the only drug class available for heartworm prevention in the United States, and strains of the heartworm parasite Dirofilaria immitis that survive preventive treatment have been documented.24PubMed Central. Moxidectin: heartworm disease prevention in dogs in the face of emerging macrocyclic lactone resistance Genetic analysis of resistant heartworm isolates found that a particular gene variant in a P-glycoprotein transporter was present at much higher frequencies in resistant strains (17 to 56%) than in susceptible ones (0 to 15%), suggesting the parasite may be using its own drug efflux pumps to survive treatment.25PubMed Central. Genetic polymorphism, constitutive expression and tissue localization of Dirofilaria immitis P-glycoprotein 11: a putative marker of macrocyclic lactone resistance Because no alternative drug class exists for heartworm prevention, the loss of macrocyclic lactone efficacy would leave veterinarians with few options. Year-round preventive dosing, mosquito control, and regular testing remain the recommended approach, but the margin for error is shrinking.
Emerging Research Beyond Parasites
Laboratory studies over the past decade have found that ivermectin can inhibit the growth of various cancer cell lines in vitro, apparently by interfering with multiple signaling pathways that tumor cells rely on to proliferate.26PubMed Central. Ivermectin, a potential anticancer drug derived from an antiparasitic drug Researchers have observed effects in cell models of breast, colon, liver, and other cancers, and some animal studies have shown tumor-slowing activity at doses higher than those used for parasite treatment.27Drug Repurposing – Molecular Aspects and Therapeutic Applications. Ivermectin: Potential Repurposing of a Versatile Antiparasitic as a Novel Anticancer
It is worth being honest about where this stands: the evidence is almost entirely preclinical. Killing cancer cells in a dish is a far lower bar than shrinking tumors in a living person, and many compounds that look promising in early-stage lab work never pan out in clinical trials. No regulatory body has approved ivermectin or any other macrocyclic lactone for cancer treatment, and the doses that showed anticancer activity in animal models raise real safety questions given the drug’s mechanism. The research is interesting and worth watching, but framing ivermectin as a cancer drug at this stage gets well ahead of the science.
How These Drugs Are Manufactured
Most macrocyclic lactones still originate from microbial fermentation rather than chemical synthesis from scratch. Streptomyces avermitilis cultures are grown in large fermentation tanks, and the target compound is extracted and purified from the broth. For compounds like doramectin, the process involves feeding a specific chemical precursor to the bacteria to direct their metabolic machinery toward the desired product. Researchers have improved fermentation yields through strain selection, mutagenesis, and optimizing growth conditions such as glucose supplementation, achieving yields of over 1,000 micrograms per milliliter in 50-liter fermenters, approaching levels suitable for industrial-scale production.28MDPI / Fermentation. Improved Fermentation Yield of Doramectin from Streptomyces avermitilis N72 by Strain Selection and Glucose Supplementation Strategies Semi-synthetic modifications are then made to the fermentation products to produce the final drug compounds. Ivermectin, for example, is created by chemically reducing a specific bond in the avermectin B1 molecule. This hybrid approach, letting bacteria do most of the complex chemistry and then making targeted tweaks, keeps manufacturing costs manageable, which matters enormously for drugs distributed in mass campaigns across dozens of low-income countries.
Tissue Persistence and Food Safety
Because macrocyclic lactones are extremely fat-soluble, they accumulate in adipose tissue and clear slowly from the bodies of treated animals. This long tissue half-life is actually beneficial for parasite control, since it means the drug stays active in the animal for weeks after a single dose. But it also means drug residues can linger in meat, milk, and other edible tissues well beyond the treatment date. Regulatory agencies set withdrawal periods, the minimum time that must pass between the last drug dose and slaughter or milking, to ensure that residue levels in food have dropped below safety thresholds. Validated laboratory methods exist to detect multiple macrocyclic lactone residues simultaneously in tissue samples, an important tool for food safety monitoring. Producers who do not respect withdrawal periods risk both regulatory action and public health consequences, since chronic low-level exposure to potent neuroactive compounds is something regulators take seriously, even when the acute risk to consumers is low.